CVS/pharmacy enters St. Louis market
WOONSOCKET, R.I. CVS/pharmacy celebrated its entry into the St. Louis market on Thursday with a grand opening at its new store in Ellisville, Mo., and a donation to the St. Louis Area Foodbank.
CVS/pharmacy has opened four stores in the St. Louis market over the past week, with a fifth location slated to open in the fall. In total, the five stores will bring about 125 new jobs to the St. Louis community this year.
“We are pleased to be opening stores in St. Louis, the 20th largest drug store market in the country. It is a great fit for our strategy of expanding into high-growth markets,” stated Larry Merlo, president of CVS/pharmacy. “Our mission at CVS is to make pharmacy solutions effective and easy for our customers, so we look forward to providing high-quality and convenient pharmacy services at a great value to our new customers in St. Louis.”
Joining CVS officials at the ceremony were Charlie A. Dooley, St. Louis County executive, and Matt Pirrello, the mayor of Ellisville.
As part of the grand opening celebration in Ellisville, CVS/pharmacy announced a $10,000 donation in funding and products to the St. Louis Area Foodbank. The donation includes a $5,000 gift in January and a $5,000 match in personal care products in February as part of a collection drive.
Throughout the month of February, CVS’ four St. Louis stores will have collection bins for customers to donate to the Foodbank nonperishable food and personal care items, such as hygiene and baby products purchased at CVS/pharmacy. CVS will match the amount of product donated by customers with an additional product donation of up to $5,000 in value.
“The St. Louis Area Foodbank is delighted to partner with CVS/pharmacy,” stated Verletta Cole, director of development for St. Louis Area Foodbank. “We appreciate CVS/pharmacy for recognizing the need and for responding so generously.”
Profession is in ‘revolutionary’ times, says NACDS’ top pharmacy official
NEEDHAM, Mass. Pharmacy practitioners need to recognize that the profession is now in the midst of “revolutionary” changes and adapt to a far more proactive role in patient outreach and community care, a top executive with the National Association of Chain Drug Stores told more than 300 leaders in health care, business, government and community activism here Tuesday.
As the health paradigm shifts, pharmacists need to leverage their strengths as “medication experts” who can coordinate healthcare efforts within the community, and put patients at the center of those efforts, said Edith Rosato, SVP pharmacy affairs for NACDS and president of the NACDS Foundation. Rosato was addressing a meeting of the Massachusetts Health Council, the nation’s the largest and oldest council devoted to health issues.
The subject of her talk: “Transforming Pharmacy Practice: Managing a Changing Environment.” In her address, Rosato tracked community pharmacy’s evolving role and its ability, as a profession, to adapt to changes in the U.S. healthcare system.
“Pharmacy is embarking on revolutionary times,” Rosato asserted. ”It is only fitting that in the nation’s birthplace — Massachusetts — I lay out the importance of revolutionary change in our field. Only by recognizing this change can we learn to adapt our protocols and practices to better position pharmacy in medication adherence activities, which [improving] health outcomes for patients while also reducing overall healthcare expenditures.
“As the face of neighborhood health care, it is not only our duty to transform to better serve our patients — it is our responsibility,” she added.
By utilizing the accessibility and credibility of pharmacy with the effective use of health information technology and management efficiencies, Rosato told members of the council, pharmacists could play an even bigger role in proactive and integrated patient-centric health care. Among the tools they already wield, she said, are medication therapy management services, vaccinations, patient counseling, and prevention-and-wellness programs.
In a bit of irony, Rosato’s appearance in Massachusetts came as voters in this state were dealing the Obama administration a serious setback in its health-reform efforts by electing Republican Scott Brown to succeed Edward Kennedy, one of the Senate’s most vocal champions of health reform before his death last year.
Brown has vowed to fight reform legislation as the 41st Republican senator, and his election breaks the filibuster-proof, 60-vote majority Democrats have held in the Senate.
JDRF, Axxam, Fast Forward to develop diabetes, MS treatments
NEW YORK A group of companies and organizations plan to collaborate to develop new treatments for multiple sclerosis and Type 1 diabetes.
Italian life sciences company Axxam, the Juvenile Diabetes Research Foundation and Fast Forward, the commercial drug development arm of the National Multiple Sclerosis Society, will fund the discovery of new drugs for the two autoimmune diseases.
Axxam will screen its chemical library to identify compounds that can target immune system ion channels, pores in the surface of immune cells that allow the cells to activate. Recent research has shown that the immune cells of patients with MS and Type 1 diabetes have high levels of the Kv1.3 ion channel, and the resulting hyperactivity contributes to dysfunction of the immune system. Meanwhile, the JDRF and Fast Forward will seek to lessen the risk of drug discovery and accelerate the development of new therapies.
“We are pleased to partner with Axxam and JDRF to advance the development of new treatments for [Type 1 diabetes] and MS,” Fast Forward president Timothy Coetzee said.